Size-Dependent in Vitro Biocompatibility and Uptake Process of Polymeric Carbon Nitride

A novel 2D g-C3N4 material applied for Paraquat adsorbing and detoxifying in vitro and in vivo

In the environmental safety area, the widespread use of the herbicide Paraquat (PQ) poses a great threat to hydrobionts and mammals. Due to the lack of specific antidote, it may lead to irreversible pulmonary fibrosis with a mortality rate of 60%. Therefore, it is necessary to develop an effective and specific PQ antidote. The g-C3N4 (HPCN) with excellent surface physicochemical properties was prepared by a two-step calcination method using urea and dicyandiamide as raw materials, showing a significant photocatalyst against environmental PQ pollution. The SEM results showed that HPCN possesses a porous layered structure. X-ray diffraction and infrared spectroscopy indicated that the conjugated aromatic rings were orderly stacked, forming a 2D layered structure of g-C3N4. The HPCN had a larger specific surface area (56.84 m2 g-1) and pore volume (0.2718 cm3 g-1), which enhanced its adsorption capacity and photocatalytic activity. HPCN exhibited an effective adsorption rate of 38.25% for PQ in water under light. Compared with the PQ group (54.8%), the cell viability of the HPCN group (91.4%) significantly increased by 36.6%, and the SEM observation revealed the restoration of normal cell morphology. The HPCN effectively reduced PQ content in zebrafish and mice in vivo, resulting in an approximately 70% increase in survival rate. The UV-Vis results indicated that the adsorption rate of HPCN for PQ in zebrafish was 43.5%. The enhanced catalytic performance of HPCN provides a promising solution for the detoxification of PQ and of other environmental pollutants.

In vivo study on borophene nanoflakes interaction with Tenebrio molitor beetle: viability of hemocytes and short-term immunity effect

The family of graphene-based materials welcomed a new member, borophene, in 2014. Research on synthesis routes and experimental study on physicochemical and biological (especially in vivo) properties still is strongly desired in order to evaluate its practical potential as a drug delivery-system. The effect of two-dimensional borophene nanoflakes on cells, systems and the entire animal organism has not been studied so far. Therefore, we investigated in vivo its biocompatibility with hemocytes in the Tenebrio molitor as a model organism. Short-term studies demonstrated that borophene nanoflakes at doses of 0.5, 1 or 2 µg of nanoflakes per insect did not induce hemocytotoxicity. Hemocytes exposed to nanoflakes showed morphology, adhesiveness and ability to form filopodia as in the control hemocytes. A detailed study indicates that borophene nanoflakes do not: (i) generate intracellular reactive oxygen species in hemocytes, (ii) affect the mitochondrial membrane potential and (iii) interfere with phagocytosis. Therefore, this contribution presents new in vivo insights into the group of two-dimensional materials which are one of the most promising materials for biomedical applications owing to their special structure and unique properties. However, long-term studies in insects and other animals are still necessary to confirm that borophene is biocompatible and biologically safe.

A novel drug delivery system -- Drug crystallization encapsulated liquid crystal emulsion

Liquid crystals (LCs) are widely used for drug delivery due to their controlled and sustained drug release properties. In this paper, drug crystallization encapsulated liquid crystal emulsion, a novel drug delivery system, was proposed. The lamellar liquid crystals formed by hydrogenated lecithin, which are similar to the skin stratum corneum lipid structure, are adopted as the drug carrier to encapsulate non-steroidal anti-inflammatory drugs (NSAIDs). As the model drug, ketoprofen exists in the hydrophobic core of emulsion as a drug crystal when squalane is used as the oil phase. The microstructure, sustained drug release behaviors, physicochemical property and biocompatibility of the system were examined by polarized light microscopy, rheological measurements, differential scanning calorimetry, X-ray diffraction, small-angle X-ray scattering, in vitro release study, and in vitro cellular cytotoxicity assay. The results have shown that the novel system lowers the drug crystal melting point and improves the thermal stability of liquid crystal structure. Besides, the excellent biocompatibility and sustained release property through the additional dissolution step of drug crystal show its application potentials in the topical cosmeceuticals. The results will also be helpful for in-depth understanding of the physical state of encapsulated drug in the liquid crystal carrier systems.

Safety and Efficacy of a Phage, kpssk3, in an in vivo Model of Carbapenem-Resistant Hypermucoviscous Klebsiella pneumoniae Bacteremia

Antimicrobial resistance (AMR) is one of the most significant threats to global public health. As antibiotic failure is increasing, phages are gradually becoming important agents in the post-antibiotic era. In this study, the therapeutic effects and safety of kpssk3, a previously isolated phage infecting carbapenem-resistant hypermucoviscous Klebsiella pneumoniae (CR-HMKP), were evaluated in a mouse model of systemic CR-HMKP infection. The therapeutic efficacy experiment showed that intraperitoneal injection with a single dose of phage kpssk3 (1 × 10⁷ PFU/mouse) 3 h post infection protected 100% of BALB/c mice against bacteremia induced by intraperitoneal challenge with a 2 × LD₁₀₀ dose of NY03, a CR-HMKP clinical isolate. In addition, mice were treated with antibiotics from three classes (polymyxin B, tigecycline, and ceftazidime/avibactam plus aztreonam), and the 7 days survival rates of the treated mice were 20, 20, and 90%, respectively. The safety test consisted of 2 parts: determining the cytotoxicity of kpssk3 and evaluating the short- and long-term impacts of phage therapy on the mouse gut microbiota. Phage kpssk3 was shown to not be cytotoxic to mammalian cells in vitro or in vivo. Fecal samples were collected from the phage-treated mice at 3 time points before (0 day) and after (3 and 10 days) phage therapy to study the change in the gut microbiome via high-throughput 16S rDNA sequence analysis, which revealed no notable alterations in the gut microbiota except for decreases in the Chao1 and ACE indexes.